Investments and investor services
Boku Inc sinks as it buys loss-making company
A look at the day's major movers, including Metals Exploration, Strategic Minerals, Challenger Acquisitions, Gresham Technologies and Countrywide
Company
C4X Discovery Holdings PLC
LON:C4XD
C4X Discovery Holdings PLC is a pioneering drug discovery company combining scientific expertise with cutting-edge drug discovery technologies to efficiently deliver world leading medicines. The company has a highly valuable and differentiated approach to drug discovery through its enhanced DNA-based target identification and candidate molecule design capabilities, generating small molecule drug candidates across multiple disease areas including inflammation, oncology, neurodegeneration and addictive disorders. C4X Discovery's commercially attractive portfolio ranges from early-stage novel target opportunities to late-stage drug discovery programmes ready for out-licensing to partners and it has two commercially partnered programmes with one candidate in clinical development.
96 stories · page 4 of 5
e-Therapeutics and C4x Discovery team up to find new Parkinson’s treatments
By combining both of their technologies, the companies think they can identify better treatments for Parkinson’s disease
Archive
FTSE 100 has worst day in over two years as Huawei CFO arrest sends shockwaves through markets
Footsie closed down 217 points today to 6,704, with 7,000 now seemingly a distant memory. .
FTSE 100 closes firmly to the good despite EU tensions
Mid-cap cousin FTSE 250 was also higher. It surged over 218 points to close at 18,584.
Archive
Pre-Thanksgiving smorgasbord as plethora of blue-chips report
A relative cornucopia of firms are scheduled to report results on Wednesday ahead of the US holiday, with a sprinkling of and UK and US economic data to taste
Archive
UK investors will have plenty of updates to chew over in the coming week as turkeys are prepared for US Thanksgiving
Aside from the inevitable Brexit drama, the Week Ahead will be dominated by another batch of corporate updates from the likes of Kingfisher, Centrica, easyJet, and Compass Group
Quiz shares strut higher as annual revenues jump
A look at some of the top risers and fallers in London today
Archive
Proactive news snapshot: C4X Discovery, Hurricane Energy, Alba Mineral Resources …
A glance at some of the day's highlights from the Proactive Investors newswire
Builders and building materials
Elektron Technology shares rise as subsidiary inks distribution agreement
A look at some of the biggest risers and fallers in London on Thursday
C4X Discovery clinches landmark US$294mln licence deal with Indivior for addiction treatment
It is the first major partnership for the AIM-listed group, which will receive US$10mln up front
Investments and investor services
FTSE 100 closes higher ending an "ugly quarter"; GKN top riser after Melrose succeeds in bid
Turnaround group Melrose received valid acceptances for its offer for GKN representing around 52.43% of the voting rights
Archive
Proactive news snapshot: Synairgen, Iofina, Atlantis Resources …
A glance at some of the day's highlights from the Proactive Investors newswire
C4X Discovery expects “significant progress” in 2018 as it looks for a partner to take its addiction drug through the clinic
“The next year will continue to focus on securing deal revenue from the commercial discussions initiated this year”
Investments and investor services
Scancell Holdings soars after "stunning endorsement" of its ImmunoBody platform
Cancer Research UK was immensely impressed with the company and its technology
C4X Discovery built for growth not a sale
To build the UK's first £1bn, self-sustainable biotech is the aim for chief executive Clive Dix
Archive
Proactive news snapshot: EG Solutions, Richland Resources, Galileo Resources …
A glance at some of the day's highlights from the Proactive Investors newswire
C4X hails progress as it starts to “see the power” of its Taxonomy3 drug discovery platform
C4X is in talks with a “number of potential pharmaceutical partners” that are keen on its drug candidates
Archive
Proactive news round-up: Statpro, Amryt Pharma, Ferrum Crescent...
A snapshot of the stories on the Proactive newswire today